A股異動丨期貨概念股走強 國債期貨准入限制放開有望帶動期市更大規模擴容
格隆匯3月5日丨期貨概念股走強,其中南華期貨(603093.SH)接近漲停,瑞達期貨(002961.SZ)大漲7.53%。經國務院同意,證監會與財政部、中國人民銀行、銀保監會已於近日發佈聯合公告,允許商業銀行、保險機構在依法合規、風險可控、商業可持續的前提下,分批推進參與中金所國債期貨交易。據證券日報,多位分析人士表示,從目前銀行和保險持有的現券市場體量來測算,將會有約400億元增量資金參與國債期貨交易。2010年股指期貨的推出,帶動了券商深度參與期貨市場,並引發了我國期貨市場的第一次擴容。有理由相信,此次允許商業銀行和保險機構參與國債期貨,也將帶來期貨市場更大規模的擴容。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.